Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

TABLE 1s. Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 8, 2020 (Week 06)
Reporting Area Invasive pneumococcal disease, all ages §
Confirmed Probable
Current weekPrevious 52 weeks Max †Cum YTD 2020 †Cum YTD 2019 †Current weekPrevious 52 weeks Max †Cum YTD 2020 †Cum YTD 2019 †
U.S. Residents, excluding U.S. Territories 227 678 2,374 2,918 3 14 44 47
New England 4 40 100 208 - 1 1 3
Connecticut - 14 3 42 - 0 - -
Maine 2 9 25 36 - 0 - -
Massachusetts - 21 50 100 - 1 1 2
New Hampshire 1 10 12 16 - 0 - -
Rhode Island - 8 1 9 - 1 - -
Vermont 1 5 9 5 - 0 - 1
Middle Atlantic 55 120 337 375 1 7 17 10
New Jersey 8 22 64 112 1 3 9 9
New York (excluding New York City) 19 90 99 98 - 4 8 -
New York City 28 44 169 124 - 3 - -
Pennsylvania - 9 5 41 - 1 - 1
East North Central 40 138 449 521 1 6 17 11
Illinois N NC N N N NC N N
Indiana - 25 42 98 - 1 - -
Michigan - 34 88 138 - 4 - 2
Ohio 38 63 249 218 1 5 17 9
Wisconsin 2 23 70 67 - 0 - -
West North Central 18 45 140 203 - 4 2 15
Iowa N NC N N N NC N N
Kansas - 11 - 42 - 1 - 1
Minnesota - 12 - - - 0 - -
Missouri 9 31 66 109 - 4 2 12
Nebraska 5 9 37 29 - 0 - 1
North Dakota 2 4 19 11 - 0 - -
South Dakota 2 6 18 12 - 2 - 1
South Atlantic 33 137 454 479 1 3 5 4
Delaware - 6 12 9 - 0 - -
District of Columbia - 5 - 9 - 0 - -
Florida 14 62 156 93 1 2 4 2
Georgia 5 38 114 152 - 0 - -
Maryland 12 23 89 81 - 1 - -
North Carolina N NC N N N NC N N
South Carolina - 33 51 85 - 2 1 2
Virginia - 3 3 3 - 0 - -
West Virginia 2 17 29 47 - 0 - -
East South Central 12 75 289 326 - 2 - 2
Alabama - 19 35 87 - 1 - -
Kentucky - 33 86 58 - 1 - 1
Mississippi 5 20 54 60 - 0 - -
Tennessee 7 29 114 121 - 2 - 1
West South Central 19 251 226 327 - 4 1 -
Arkansas 5 33 45 47 - 0 - -
Louisiana - 22 41 74 - 1 - -
Oklahoma N NC N N N NC N N
Texas 14 203 140 206 - 4 1 -
Mountain 46 91 375 443 - 2 1 1
Arizona 27 37 170 156 - 2 1 -
Colorado 16 23 101 90 - 1 - -
Idaho N NC N N N NC N N
Montana - 8 6 20 - 1 - -
Nevada - 17 18 68 - 0 - -
New Mexico 1 14 44 69 - 0 - -
Utah - 12 26 36 - 1 - 1
Wyoming 2 4 10 4 - 0 - -
Pacific - 11 4 36 - 1 - 1
Alaska - 6 - 24 - 1 - 1
California N NC N N N NC N N
Hawaii - 8 4 12 - 0 - -
Oregon N NC N N N NC N N
Washington N NC N N N NC N N
U.S. Territories - 0 - - - 0 - -
American Samoa N NC N N N NC N N
Commonwealth of Northern Mariana Islands - 0 - - - 0 - -
Guam - 0 - - - 0 - -
Puerto Rico - 0 - - - 0 - -
U.S. Virgin Islands - 0 - - - 0 - -
Non-U.S. Residents - 0 - - - 0 - -
Total 227 678 2,374 2,918 3 14 44 47
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • Max: Maximum — Maximum case count during the previous 52 weeks.
  • * Case counts for reporting years 2019 and 2020 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf.
  • †Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Includes drug resistant and susceptible cases of Invasive Pneumococcal Disease.